Neogenomics Inc (NASDAQ:NEO)

7.52
Delayed Data
As of Feb 16
 -0.08 / -1.05%
Today’s Change
7.08
Today|||52-Week Range
11.63
-15.12%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +46.28% increase from the last price of 7.52.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.04
Sales
$66.3M
Reporting Date
Feb 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 287.50%
 
 
 
 
 
 
Growthannually -20.74%
 
 
 
 
 
 

Sales

Growthquarterly 5.19%
 
 
 
 
 
 
Growthannually 5.34%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.